Skip to main content
SpringerLink
Log in

Type III procollagen as a biomarker of susceptibility to ARDS?

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Forel JM, Guervilly C, Hraiech S, Voillet F et al (2015) Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation. Intensive Care Med 41(1):1–11. doi:10.1007/s00134-014-3524-0

    Article  CAS  PubMed  Google Scholar 

  2. Chesnutt AN, Matthay MA, Tibayan FA, Clark JG (1997) Early detection of type III procollagen peptide in acute lung injury—pathogenetic and prognostic significance. Am J Respir Crit Care Med 156(3):840–845

    Article  CAS  PubMed  Google Scholar 

  3. Clark JG, Milberg JA, Steinberg KP, Hudson LD (1995) Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 122(1):17–23

    Article  CAS  PubMed  Google Scholar 

  4. Proudfoot AG, McAuley AF, Griffiths MJD, Hind M (2011) Human models of acute lung injury. Dis Model Mech 4(2):145–153

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Craig TR, Duffy MJ, Shyamsundar M, McDowell C et al (2011) A randomized clinical trial of hydroxymethylglutaryl–coenzyme a reductase inhibition for acute lung injury (the HARP study). Am J Respir Crit Care Med 183:620–626

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

  1. University of Glasgow, Glasgow, UK

    A. Arthur, P. J. McCall, L. Jolly, J. Kinsella & B. Shelley

  2. Golden Jubilee National Hospital, Glasgow, UK

    A. Macfie & A. Kirk

Authors
  1. A. Arthur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. J. McCall
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Macfie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Jolly
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Kinsella
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Kirk
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Shelley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Arthur.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arthur, A., McCall, P.J., Macfie, A. et al. Type III procollagen as a biomarker of susceptibility to ARDS?. Intensive Care Med 41, 568–569 (2015). https://doi.org/10.1007/s00134-015-3645-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-015-3645-0

Keywords

Search

Navigation